NDA Meeting with the FDA Scheduled for Early December; NDA Submission for D-PLEX₁₀₀ On Track for Early 2026 Advancements in Discussions with Potential U.S. Partners Following Positive Phase 3 Trial ...
Bhangu, J. , Sweetman, S. , Williams, G. and Shuttleworth, G. (2025) Patient Footwear Contamination in Ophthalmic Day Surgery: A Prospective Observational Study. International Journal of Clinical ...
Face-to-Face Pre-NDA Meeting with the FDA Scheduled for Early December; NDA Submission for D-PLEX100 On Track for Early 2026 Advancements in Discussions with Potential U.S. Partners Following Positive ...
If you’ve already started your estate planning, congratulations — you’re ahead of the curve and protecting what matters most! As of 2025, only about 24% of American adults have a will or estate plan, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback